Cargando…

Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following High-Risk Exposure

BACKGROUND: Non-pharmaceutical interventions (NPIs) are recommended for COVID-19 prevention. However, the effectiveness of NPIs in preventing SARS-CoV-2 transmission remains poorly quantified. METHODS: We conducted a test-negative design case-control study enrolling cases (testing positive for SARS-...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrejko, Kristin L, Pry, Jake, Myers, Jennifer F, Openshaw, John, Watt, James, Birkett, Nozomi, DeGuzman, Jennifer L, Barbaduomo, Camilla M, Dong, Zheng N, Fang, Anna T, Frost, Paulina M, Ho, Timothy, Javadi, Mahsa H, Li, Sophia S, Tran, Vivian H, Wan, Christine, Jain, Seema, Lewnard, Joseph A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903328/
https://www.ncbi.nlm.nih.gov/pubmed/34932817
http://dx.doi.org/10.1093/cid/ciab1040
_version_ 1784664737231929344
author Andrejko, Kristin L
Pry, Jake
Myers, Jennifer F
Openshaw, John
Watt, James
Birkett, Nozomi
DeGuzman, Jennifer L
Barbaduomo, Camilla M
Dong, Zheng N
Fang, Anna T
Frost, Paulina M
Ho, Timothy
Javadi, Mahsa H
Li, Sophia S
Tran, Vivian H
Wan, Christine
Jain, Seema
Lewnard, Joseph A
author_facet Andrejko, Kristin L
Pry, Jake
Myers, Jennifer F
Openshaw, John
Watt, James
Birkett, Nozomi
DeGuzman, Jennifer L
Barbaduomo, Camilla M
Dong, Zheng N
Fang, Anna T
Frost, Paulina M
Ho, Timothy
Javadi, Mahsa H
Li, Sophia S
Tran, Vivian H
Wan, Christine
Jain, Seema
Lewnard, Joseph A
author_sort Andrejko, Kristin L
collection PubMed
description BACKGROUND: Non-pharmaceutical interventions (NPIs) are recommended for COVID-19 prevention. However, the effectiveness of NPIs in preventing SARS-CoV-2 transmission remains poorly quantified. METHODS: We conducted a test-negative design case-control study enrolling cases (testing positive for SARS-CoV-2) and controls (testing negative) with molecular SARS-CoV-2 diagnostic test results reported to California Department of Public Health between 24 February–12 November, 2021. We used conditional logistic regression to estimate adjusted odds ratios (aORs) of case status among participants who reported contact with an individual known or suspected to have been infected with SARS-CoV-2 (“high-risk exposure”) ≤14 days before testing. RESULTS: 751 of 1448 cases (52%) and 255 of 1443 controls (18%) reported high-risk exposures ≤14 days before testing. Adjusted odds of case status were 3.02-fold (95% confidence interval: 1.75–5.22) higher when high-risk exposures occurred with household members (vs. other contacts), 2.10-fold (1.05–4.21) higher when exposures occurred indoors (vs. outdoors only), and 2.15-fold (1.27–3.67) higher when exposures lasted ≥3 hours (vs. shorter durations) among unvaccinated and partially-vaccinated individuals; excess risk associated with such exposures was mitigated among fully-vaccinated individuals. Cases were less likely than controls to report mask usage during high-risk exposures (aOR = 0.50 [0.29–0.85]). The adjusted odds of case status was lower for fully-vaccinated (aOR = 0.25 [0.15–0.43]) participants compared to unvaccinated participants. Benefits of mask usage were greatest among unvaccinated and partially-vaccinated participants, and in interactions involving non-household contacts or interactions occurring without physical contact. CONCLUSIONS: NPIs reduced the likelihood of SARS-CoV-2 infection following high-risk exposure. Vaccine effectiveness was substantial for partially and fully vaccinated persons.
format Online
Article
Text
id pubmed-8903328
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-89033282022-03-09 Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following High-Risk Exposure Andrejko, Kristin L Pry, Jake Myers, Jennifer F Openshaw, John Watt, James Birkett, Nozomi DeGuzman, Jennifer L Barbaduomo, Camilla M Dong, Zheng N Fang, Anna T Frost, Paulina M Ho, Timothy Javadi, Mahsa H Li, Sophia S Tran, Vivian H Wan, Christine Jain, Seema Lewnard, Joseph A Clin Infect Dis Major Article BACKGROUND: Non-pharmaceutical interventions (NPIs) are recommended for COVID-19 prevention. However, the effectiveness of NPIs in preventing SARS-CoV-2 transmission remains poorly quantified. METHODS: We conducted a test-negative design case-control study enrolling cases (testing positive for SARS-CoV-2) and controls (testing negative) with molecular SARS-CoV-2 diagnostic test results reported to California Department of Public Health between 24 February–12 November, 2021. We used conditional logistic regression to estimate adjusted odds ratios (aORs) of case status among participants who reported contact with an individual known or suspected to have been infected with SARS-CoV-2 (“high-risk exposure”) ≤14 days before testing. RESULTS: 751 of 1448 cases (52%) and 255 of 1443 controls (18%) reported high-risk exposures ≤14 days before testing. Adjusted odds of case status were 3.02-fold (95% confidence interval: 1.75–5.22) higher when high-risk exposures occurred with household members (vs. other contacts), 2.10-fold (1.05–4.21) higher when exposures occurred indoors (vs. outdoors only), and 2.15-fold (1.27–3.67) higher when exposures lasted ≥3 hours (vs. shorter durations) among unvaccinated and partially-vaccinated individuals; excess risk associated with such exposures was mitigated among fully-vaccinated individuals. Cases were less likely than controls to report mask usage during high-risk exposures (aOR = 0.50 [0.29–0.85]). The adjusted odds of case status was lower for fully-vaccinated (aOR = 0.25 [0.15–0.43]) participants compared to unvaccinated participants. Benefits of mask usage were greatest among unvaccinated and partially-vaccinated participants, and in interactions involving non-household contacts or interactions occurring without physical contact. CONCLUSIONS: NPIs reduced the likelihood of SARS-CoV-2 infection following high-risk exposure. Vaccine effectiveness was substantial for partially and fully vaccinated persons. Oxford University Press 2021-12-21 /pmc/articles/PMC8903328/ /pubmed/34932817 http://dx.doi.org/10.1093/cid/ciab1040 Text en © The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_modelThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
spellingShingle Major Article
Andrejko, Kristin L
Pry, Jake
Myers, Jennifer F
Openshaw, John
Watt, James
Birkett, Nozomi
DeGuzman, Jennifer L
Barbaduomo, Camilla M
Dong, Zheng N
Fang, Anna T
Frost, Paulina M
Ho, Timothy
Javadi, Mahsa H
Li, Sophia S
Tran, Vivian H
Wan, Christine
Jain, Seema
Lewnard, Joseph A
Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following High-Risk Exposure
title Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following High-Risk Exposure
title_full Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following High-Risk Exposure
title_fullStr Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following High-Risk Exposure
title_full_unstemmed Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following High-Risk Exposure
title_short Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following High-Risk Exposure
title_sort predictors of severe acute respiratory syndrome coronavirus 2 infection following high-risk exposure
topic Major Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903328/
https://www.ncbi.nlm.nih.gov/pubmed/34932817
http://dx.doi.org/10.1093/cid/ciab1040
work_keys_str_mv AT andrejkokristinl predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure
AT pryjake predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure
AT myersjenniferf predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure
AT openshawjohn predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure
AT wattjames predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure
AT birkettnozomi predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure
AT deguzmanjenniferl predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure
AT barbaduomocamillam predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure
AT dongzhengn predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure
AT fangannat predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure
AT frostpaulinam predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure
AT hotimothy predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure
AT javadimahsah predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure
AT lisophias predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure
AT tranvivianh predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure
AT wanchristine predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure
AT jainseema predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure
AT lewnardjosepha predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure
AT predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure